Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia

NCT02914977 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphocytic Leukemia
Acute Myeloid Leukemia

Interventions

DRUG: Daunorubicin

Sponsor

Tara Lin